Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$51.76 - $64.15 $11.1 Million - $13.7 Million
213,749 Added 64.71%
544,042 $29.8 Million
Q1 2024

May 15, 2024

BUY
$48.6 - $57.12 $16.1 Million - $18.9 Million
330,293 New
330,293 $18.5 Million
Q4 2021

Feb 14, 2022

SELL
$76.72 - $92.68 $12.8 Million - $15.4 Million
-166,575 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$76.02 - $88.62 $38,314 - $44,664
504 Added 0.3%
166,575 $13.2 Million
Q2 2021

Aug 16, 2021

SELL
$73.44 - $87.01 $1.26 Million - $1.49 Million
-17,160 Reduced 9.37%
166,071 $14 Million
Q1 2021

May 17, 2021

SELL
$62.9 - $82.41 $469,171 - $614,696
-7,459 Reduced 3.91%
183,231 $13.5 Million
Q4 2020

Feb 16, 2021

BUY
$46.01 - $68.74 $8.77 Million - $13.1 Million
190,690 New
190,690 $12.6 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.